Stockreport

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monoth...

Molecular Templates, Inc.  (MTEM) 
Last molecular templates, inc. earnings: 11/12 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.mtem.com/investor-relations
PDF biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel thera [Read more]